Obesity and blunted FGF23 response associate with kidney impairment in patients with hypoparathyroidism
For the first-time, obesity was demonstrated to be independently associated with CKD in patients with hypoparathyroidism, and a blunted eGFR-related response of FGF23 was shown in patients with CKD potentially worsening the renal function in the context of hypoparathyroidism.
Authors
- Barbara Presciuttini
- Marta Villanova
- Claudio Marelli (ORCID: https://orcid.org/0000-0002-5783-1142)
- Andrea Giustina (ORCID: https://orcid.org/0000-0001-6783-3398)
- Giuseppe Vezzoli (ORCID: https://orcid.org/0000-0003-4481-5693)
- Anna Maria Formenti (ORCID: https://orcid.org/0000-0002-3553-8762)
- Agnese Allora
- Luigi di Filippo (ORCID: https://orcid.org/0009-0002-6117-0081)
- Francesca Ferrari (ORCID: https://orcid.org/0000-0003-4093-2198)
- Massimo Locatelli (ORCID: https://orcid.org/0000-0002-2851-712X)
- Maria Luisa Brandi (ORCID: https://orcid.org/0000-0001-9309-6248)
- Antonino Russo
Institutions
- Vita-Salute San Raffaele University (IT)
- Ospedale Santa Chiara (IT)
- IRCCS Ospedale San Raffaele (IT)
- Bridge Pharma (United States) (US)
Publication Details
- Journal
- Endocrine
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1007/s12020-025-04221-y
- Citations
- 1
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- Takeda Pharmaceuticals International